Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.

Abstract

BACKGROUND Adjuvant chemotherapy has been demonstrated to improve the outcomes of patients with N1 non-small cell lung cancer. It is unknown whether patients previously thought to have unresectable small cell lung cancer (SCLC) may have tumors amenable to surgery if adjuvant therapies can be given. This study was undertaken to evaluate whether surgery, in… (More)
DOI: 10.1016/j.athoracsur.2017.01.043

Topics

Cite this paper

@article{Yang2017SurgeryVO, title={Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.}, author={Chi-fu Jeffrey Yang and Derek Y Chan and Paul J. Speicher and Brian C H Gulack and Betty Caroline Tong and Matthew G. Hartwig and Christopher R Kelsey and Thomas A D'amico and Mark F. Berry and David H. Harpole}, journal={The Annals of thoracic surgery}, year={2017}, volume={103 6}, pages={1767-1772} }